Keyphrases
Vaccine Adjuvant
100%
Cellular Response
100%
Liposomes
100%
Protein Vaccine
100%
TLR Agonists
100%
Humoral Response
100%
Small Unilamellar Vesicles
66%
Ovalbumin
50%
Multilamellar Vesicles
33%
Immunogenic
33%
Reactogenicity
33%
Clinical Application
16%
Spleen
16%
Dehydration-rehydration
16%
Protein Antigen
16%
High Capacity
16%
CD8+ T Cell Response
16%
Subunit Vaccine
16%
Immunization
16%
Immune Signaling
16%
CD-8
16%
Adjuvanted
16%
Multilamellar
16%
Unilamellar
16%
Associated Antigen
16%
Vaccine Components
16%
Human Trials
16%
Antigen-specific Antibody
16%
Safety Risk
16%
TLR9 Agonist
16%
Lipid Membrane
16%
Spherical Vesicles
16%
Protein-ligand
16%
TLR3 Agonist
16%
Phospholipid Bilayer
16%
Aqueous Buffer
16%
Immunostimulator
16%
Protective Immune Response
16%
Model Proteins
16%
Medicine and Dentistry
Vaccine Adjuvant
100%
Liposome
100%
Humoral Immunity
100%
Ovalbumin
50%
Reactogenicity
33%
Immune Response
16%
Pathogen
16%
Antibodies
16%
Antigen
16%
Clinical Trial
16%
Buffer
16%
Subunit Vaccine
16%
T-Cell Response
16%
CD8 Antigen
16%
Adjuvant
16%
Membrane Lipid
16%
Protein Ligand
16%
Immune System Receptors
16%
Cytotoxic T-Cell
16%
Toll Like Receptor 3
16%
Toll Like Receptor 9
16%
Phospholipid Bilayer
16%
Immunology and Microbiology
Vaccine Adjuvant
100%
Humoral Immunity
100%
Agonist
100%
Antigen
20%
Immune Response
20%
Infectious Agent
20%
Antibodies
20%
Cytotoxic T-Cell
20%
CD8
20%
Subunit Vaccine
20%
Adjuvant
20%
TLR9
20%
Phospholipid Bilayer
20%
TLR3
20%
Immune System Receptors
20%
Pharmacology, Toxicology and Pharmaceutical Science
Vaccine Adjuvant
100%
Liposome
100%
Ovalbumin
50%
CD8 Antigen
33%
Receptor
16%
Buffer
16%
Subunit Vaccine
16%
Infectious Agent
16%
Adjuvant
16%
Clinical Trial
16%
Antibodies
16%
Phospholipid
16%
Antigen
16%
Protein Ligand
16%
Toll Like Receptor 9
16%
Membrane Lipid
16%
Toll Like Receptor 3
16%